We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$46M
(+35%)
Cap. Flow
+$35.6M
Cap. Flow
% of AUM
20.25%
Top 10 Holdings %
Top 10 Hldgs %
67.87%
Holding
23
New
–
Increased
21
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$15.9M |
| 2 |
Comcast
CMCSA
|
+$3.68M |
| 3 |
Cigna
CI
|
+$3.43M |
| 4 |
Antero Resources
AR
|
+$3.05M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$2.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$12.6M |
| 2 |
Vistra
VST
|
+$3.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 20.53% |
| 2 | Healthcare | 19.94% |
| 3 | Energy | 17.27% |
| 4 | Technology | 10.5% |
| 5 | Communication Services | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Newmont
NEM
$98.7B
| $18.8M | 10.69% |
222,600
+23,250
| +12% | +$1.62M |
|
|
2
Vistra
VST
$54.7B
| $16.6M | 9.43% |
84,515
-15,935
| -16% | -$3.16M |
|
|
3
Chevron
CVX
$381B
| $16.2M | 9.25% |
104,622
+102,804
| +5,655% | +$15.9M |
|
4
Vicor
VICR
$9.79B
| $12.6M | 7.2% |
254,140
+23,940
| +10% | +$1.17M |
|
5
Alphabet (Google) Class A
GOOGL
$4.24T
| $11.2M | 6.38% |
46,100
+7,925
| +21% | +$1.66M |
|
6
CVS Health
CVS
$141B
| $9.89M | 5.63% |
131,205
+27,863
| +27% | +$1.91M |
|
7
The Mosaic Company
MOS
$6.98B
| $9.69M | 5.52% |
279,275
+51,275
| +22% | +$1.77M |
|
|
8
Antero Resources
AR
$10.5B
| $8.54M | 4.87% |
254,550
+91,550
| +56% | +$3.05M |
|
|
9
Bristol-Myers Squibb
BMY
$124B
| $8.03M | 4.57% |
178,025
+54,025
| +44% | +$2.52M |
|
10
Nutrien
NTR
$32.1B
| $7.6M | 4.33% |
128,150
+33,650
| +36% | +$1.96M |
|
|
11
Comcast
CMCSA
$85.1B
| $6.93M | 3.94% |
220,425
+109,700
| +99% | +$3.68M |
|
|
12
Cigna
CI
$76.8B
| $6.49M | 3.69% |
22,500
+11,600
| +106% | +$3.43M |
|
13
Bunge Global
BG
$23.4B
| $6.38M | 3.64% |
78,550
+29,550
| +60% | +$2.37M |
|
14
L3Harris
LHX
$51.7B
| $6.05M | 3.44% |
19,800
+5,800
| +41% | +$1.59M |
|
15
International Paper
IP
$19.2B
| $5.84M | 3.32% |
125,780
+46,030
| +58% | +$2.25M |
|
16
AbbVie
ABBV
$452B
| $5.75M | 3.27% |
24,820
+6,320
| +34% | +$1.29M |
|
17
SLB Ltd
SLB
$69.7B
| $5.53M | 3.15% |
159,500
+47,500
| +42% | +$1.65M |
|
18
Qualcomm
QCOM
$183B
| $5.35M | 3.05% |
32,165
+8,665
| +37% | +$1.37M |
|
19
Medtronic
MDT
$107B
| $4.85M | 2.77% |
50,595
+15,355
| +44% | +$1.41M |
|
20
Berkshire Hathaway Class B
BRK.B
$1.06T
| $2.31M | 1.31% |
4,590
+1,090
| +31% | +$528K |
|
21
JPMorgan Chase
JPM
$918B
| $505K | 0.29% |
1,600
+100
| +7% | +$29.7K |
|
22
Apple
AAPL
$4.81T
| $446K | 0.25% |
1,750
+600
| +52% | +$136K |
|
|
HES
23
DELISTED
Hess
HES
| – | – |
-90,925
| Closed | -$12.6M |
|
Similar funds
NAM
CCAM
QP
BFA
PW
BFP
TC
FC
Colrain Capital's Q3 2025 Portfolio in Review
As of Q3 2025, Colrain Capital held 23 positions worth $176M, up 35% from $130M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Colrain Capital deployed $35.6M of net new capital in Q3 2025, adding to 21 existing holdings.
By sector, the portfolio is most concentrated in Materials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Vistra, an estimated $3.16M trimmed.
- Colrain Capital added most to Chevron in Q3 2025, an estimated $15.9M increase.
- Colrain Capital's biggest Q3 2025 reduction was Vistra, cutting an estimated $3.16M.
- Colrain Capital fully exited Hess in Q3 2025, selling an estimated $12.6M.
- Colrain Capital's ten largest holdings make up 68% of its $176M portfolio in Q3 2025.
- Colrain Capital opened 0 new positions and closed 1 in Q3 2025.
- Colrain Capital's portfolio value rose 35% quarter-over-quarter to $176M.
Based on Colrain Capital's 13F filing for Q3 2025, filed 7 Nov 2025.